2. • Definition of diabetes
• Types of diabetes
• Metabolic derangements in diabetes
• Clinical presentations
• Acute & chronic complications of
diabetes
• Laboratory investigations
• Management
3. • Diabetes mellitus is metabolic cum vascular
syndrome of multiple etiology characterized by
chronic hyperglycemia with disturbance of
carbohydrate, fat & protein metabolism
• May be due to defect in insulin secretion ,
insulin action or both.
• Leading to changes in small blood
vessels(microangiopathy) & large
blood vessels(macroangiopathy)
4. • DM is disease known from very ancient times
• Charaka (400 BC) : elaborate clinical description of
Madhumeha
• 1670: Thomas willis noticed sweet taste of Diabeticurine
• 1848: Fehling discovered qualitative test for urinesugar
• 1908: Benedict discovered reagent for semi-quantitativetest for urine
sugar
• 1919: Folin identified quantitative method fordetermination of blood
glucose
5. • Worldwide, more than 425 million adults sufferfrom Diabetes.
• T2DM comprises 85-95% of all cases of DM
• Occurs even in non obese people. Occasionally seenin children
also
• More prone to develop cardiovasculardisease
• Top 5 countries : China, India, USA, Brazil, Mexico
• In India T2DM occurs a decade earlier than in thewest
6. As per American DiabetesAssociation(ADA)
1. HbA1C > 6.5%
2. FPG > 126 mg/dL
3. 2 hrs PP > 200 mg/dL
4. If both fasting & 2 hr values are above normalon same
occasion
5. Random plasma glucose > 200 mg/dL on 2 occasions
7. 4 main types
1.Type 1 Diabetes Mellitus: β- cell destruction, usually leading to absolute
insulin deficiency)
a. Immune mediated
b. Idiopathic
2. Type 2 Diabetes Mellitus : may range from predominant IR with
relative insulin deficiency to a predominant secretory defect with IR)
3. Other specific types:
a. MODY
b. Endocrinopathies: Cushing’s, Thyrotoxicosis,Acromegaly
c. Drug or chemical induced: steroids, β- blockers,etc
d. Pancreatic diseases: FCPD, chronic pancreatitis, cystic fibrosis.
4. Gestational diabetes mellitus (GDM)
8. • Absolute insulin deficiency due to destruction of β-cells
• Patient depends on insulin injection for survival &health
Epidemiology
5 – 10% of all individuals with diabetes haveT1DM
Onset at childhood / adolescence (usually <30 yrs of age)
Symptoms
Abrupt onset of severe symptoms
May present with DKA
Antibodies
Anti-insulinAb
Anti islet cellAb
9. TYPE 2 DIABETES MELLITUS
• About 60% of patients are obese
• They have high plasma insulinlevels.
10.
11. Ask for symptoms of Diabetes
Polyuria
Polydipsia (Thirsty)
Polyphagia (Hunger)
Weight loss
Delayed wound healing
Tiredness
Itching especially in the genitalarea
Tingling & numbness
Visual disturbances
>60% of the patients do not have anysymptoms
16. 1. Diabetic ketoacidosis (DKA)
• Most common in T1DM
• FFAbreakdown more acetyl-CoAavailable but it cannot be
efficiently oxidized by TCA cycle, because of limited availability of
oxaloacetate.
• The excess acetyl-CoA, is diverted to ketonebodies
production , leading to ketonemia & ketonuria
• Normally the ketone bodies level in blood is <1mg/dL,only traces
excreted in urine
• But when the rate of synthesis exceeds the abilityof
extrahepatic tissues to utilize them accumulation
• Ketosis: Ketonemia, Ketonuria, Acetone smell inbreath
17. Diagnosis:
• Rothera’s test: saturate 5 ml of urine with solidammonium
sulfate few drops of freshly prepared sodium nitroprusside
2ml of liquid ammonia along the sides of the test tube
purple ring presence of ketone bodies in urine.
Supportive evidence:
• Estimation of serum electrolytes
• ABG
• Glucose estimation
18. • Metabolic acidosis: Acetoacetate & β hydroxybutyrate are
acids. When they accumulate Metabolic acidosis. There
will be increased anion gap
• Reduced buffers: the plasma bicarbonate is used forbuffering
these acids
• Kussmaul’s respiration: Acidotic breathing due to
compensatory hyperventilation
• Smell of acetone in breath
• Osmotic diuresis: induced by ketonuria dehydration
• Sodium loss: ketone bodies are excreted in urine astheir
sodium salt
19. • High potassium: due to lowered uptake of potassium
by cells with the absence of insulin
• Dehydration: The sodium loss further aggravates
the dehydration
• Coma
20. • IV insulin infusion
• IV bicarbonate to correct acidosis
• IV saline to correct sodium & waterimbalance
• IV potassium infusion: With insulin infusion, more potassium
moves from ECF to ICF Hypokalemia. Potassium infusion
should be started along withinsulin infusion.
21. HHS: Hyperosmolar hyperglycemic state
• Marked hyperglycemia (extremely high)
• Profound dehydration
• High plasma osmolarity
• Normal pH
• Severe CNS obtundation: stupor, coma, convulsions
• Focal neurological sign : hemisensory deficits,hemiparesis, aphasia &
seizures
• Ketonemia, ketonuria & metabolic acidosis absent
• Typically presents in elderly T2DM patients withother significant
comorbidities
22. • Plasma glucose: usually much higher than DKA
• Plasma osmolarity : > 320mosm/L
• Serum pH : Normal or only slightly reduced
• Serum Bicarbonate: > 15 mEq/L
• Urine & serum ketones: Negative
• Serum sodium & potassium : Decreased
23. • Patient needs immediate hospitalization
• Primary treatment goal: To correct hyperosmolar state &
dehydration
• Adequate fluid replacement insulin therapy: same asDKA
• Potassium replacement: same as DKA
• Bicarbonate replacement : not necessary
24. 3. Lactic acidosis
• Relatively rare complication of diabetes
• In earlier days, it was seen in patients treatedwith Biguanides
(Tolbutamide)
• The newer preparation Metformin do not have thiseffect
• Due to overproduction and/or underutilization of lacticacid
• Another important cause of lactic acidosis:Excessive alcohol
consumption
25. • Hypoglycemia is defines as a clinical state with low plasma glucose
levels usually associated with signs & symptoms of autonomic
hyperactivity & neuroglycopenia.
• ADA : Plasma glucose < 54 mg/dL
Plasma glucose < 70 mg/dL (alert value)
• Common side effect of treatment with insulin & sulfonylurea drug
• The neural tissue requires continuous supply ofglucose
• If this supply is interrupted even for few minutes CNS
dysfunction, impaired cognition & coma.
• Thus avoidance of hypoglycemia is a very crucial factor in the
management of Diabetes.
27. Excessive dosage
Error by doctor, patient or
pharmacist
Poor matching to patient’s
needs or lifestyle
Deliberate overdose
Increased bioavailability
Accelerated absorption
Renal failure (reduced
insulin clearance)
Other factors
Exercise
Alcohol: inhibits
hepatic glucose
production
Drugs: Sulfonylureas,
non- selective β blockers,
etc
28. Hypoglycemia- Treatment
If patient is conscious
• Oral carbohydrate: Sugar, Candy, Orange juice, Glucose
• Check blood glucose 15-20 minutes. Confirm recovery
• After recovery : identify cause, re-educate, take measures to avoid
hypoglycemia
If patient unconscious
• IV Glucose : 100 mL of 25% solution
• Glucagon 1 mg S.C or IM injection
• Check blood glucose 15-20 minutes. Confirm recovery
• If not recovered IV 5% or 10% glucose
• After recovery : identify cause, re-educate, take measures to avoid
hypoglycemia
29. Prevention strategies for hypoglycemia
• Regularity of diet, insulin & exercise
• Between- meal & bedtime snacks
• Regular blood glucose testing
• Keeping sugar, candy or glucose tablets handy at alltimes
• Education regarding subtle changes of hypoglycemia
• Identification card
• Use of analog insulin
30. • Maturity onset diabetes of young
• Mutation in single gene – monogenicdiabetes
• Presents during childhood & adolescence
• Defective insulin secretion of betacell
• Diagnosis : Genetic testing (Gold standard but veryexpensive)
3.MODY
31. 4. Gestational Diabetes Mellitus (GDM)
Gestational Diabetes mellitus (GDM) is defined as any degree of impaired
glucose tolerance of with onset or first recognition during pregnancy.
Many are denovo pregnancy induced
some are type 2(35-40%)
10 % have antibodies
Risk factors: Race, PCOS,FH of Diabetes, Obesity, Age older than
25years,persisitant glucosuria.
35. Glycated Hemoglobin (HbA1c)
• Best index for long-term control of bloodglucose
• Glycosylation: enzymatic addition of any sugar to aprotein
• Glycation : Non-enzymatic process
• In hyperglycemia, proteins in the body undergo glycation
• Once attached, Glucose will not be removed from theHb
• It remains inside the RBC, throughout its life span(120days)
36. • Reveals mean glucose level over the previous 10-12weeks
• Unaffected by recent food intake or change inblood
glucose level
• Expressed as fraction of total Hb
• Normal
• Impaired
• DM
• Good control
• Adequate control
• Inadequate control
• Poor control
: <5.5%
: 5.6 – 6.4%
: > 6.5%
: 6.0%
: 7%
: 8%
: > 9%
37. 4 testing methods currently available
HPLC assay : Gold standard
Ab- based latex enhanced immunoassay
Enzyme based enzymatic assay
Ion exchange chromatography
• No fasting required
• Low intra individual variability
• Values not altered by acute factors
• Reflects long term glucosecontrol
• Better index for predicting complications
38. Diet & Exercise
• First line
• Diet should be tailored to each patient
• Balanced diet with high protein, low calories, devoid of
saturated fat & refined sugars with adequate PUFA,fiber
• Vegetables: major source of minerals, vitamins & fiber
• Exercise of minimum 150 minutes per week or more
• Brisk walking with strengthening exercises